Existing medications among non-pregnancy-related listeriosis patients in England, 2007-2009

Epidemiology and Infection

Volumn 141, Issue 1, 2013, Pages 36-44

  Mook, P ^a   Jenkins, J M ^b   O'Brien, S J ^c   Gillespie, I A ^d,e  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NHS Derbyshire County   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d AMGEN LTD   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

British National Formulary; epidemiology; Listeria monocytogenes; listeriosis; medications; surveillance

Indexed keywords

ANTIANEMIC AGENT; ANTICOAGULANT AGENT; ANTIRHEUMATIC AGENT; BIOLOGIC FACTORS AND AGENTS ACTING ON THE IMMUNE SYSTEM; CORTICOSTEROID; CYTOTOXIC AGENT; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; HEMATOLOGIC AGENT; MINERAL; PROTAMINE; STOMACH SECRETION INHIBITOR; VITAMIN;

ADULT; DRUG USE; FEMALE; FOOD SAFETY; HUMAN; INCIDENCE; LISTERIOSIS; MALE; NATIONAL HEALTH SERVICE; PRESCRIPTION; REVIEW; UNITED KINGDOM;

ADULT; AGED; DRUG THERAPY; DRUG UTILIZATION; ENGLAND; FEMALE; HUMANS; LISTERIOSIS; MALE; MIDDLE AGED;

EID: 84870920389     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881200026X     Document Type: Review

References (26)

1. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbioiological Reviews 1991; 55: 476-511. (Pubitemid 21895164)
2. Gillespie IA, et al. Changing pattern of human listeriosis, England and Wales, 2001-2004. Emerging Infectious Diseases 2006; 12: 1361-1366. (Pubitemid 44455212)
3. Guevara RE, Mascola L, Sorvillo F. Risk factors for mortality among patients with nonperinatal listeriosis in Los Angeles County, 1992-2004. Clinical Infectious Diseases 2009; 48: 1507-1515.
4. McLauchlin J. Human listeriosis in Britain, 1967-85, a summary of 722 cases. 2. Listeriosis in non-pregnant individuals, a changing pattern of infection and seasonal incidence. Epidemiology and Infection 1990; 104: 191-201. (Pubitemid 20300132)
5. Gerner-Smidt P, et al. Invasive listeriosis in Denmark 1994-2003: A review of 299 cases with special emphasis on risk factors for mortality. Clinical Microbiology and Infection 2005; 11: 618-624. (Pubitemid 41051377)
6. Goulet V, Marchetti P. Listeriosis in 225 non-pregnant patients in 1992: Clinical aspects and outcome in relation to predisposing conditions. Scandinavian Journal of Infectious Diseases 1996; 28: 367-374. (Pubitemid 26316997)
7. Mook P, Patel B, Gillespie IA. Risk factors for mortality in non-pregnancy-related listeriosis. Epidemiology and Infection 2012; 140: 706-715.
8. Siegman-Igra Y, et al. Listeria monocytogenes infection in Israel and review of cases worldwide. Emerging Infectious Diseases 2002; 8: 305-310. (Pubitemid 34266269)
9. Goulet V, et al. Increasing incidence of listeriosis in France and other European countries. Emerging Infectious Diseases 2008; 14: 734-740. (Pubitemid 351838636)
10. Koch J, Stark K. Significant increase of listeriosis in Germany - epidemiological patterns 2001-2005. Eurosurveillance 2006; 11: 85-88.
11. Kvistholm JA, et al. Substantial increase in listeriosis, Denmark 2009. Eurosurveillance 2010; 15.
12. Mook P, O'Brien SJ, Gillespie IA. Concurrent conditions and human listeriosis, England, 1999-2009. Emerging Infectious Diseases 2011; 17: 38-43.
13. Health Protection Agency. Questionnaires for the surveillance of Listeria monocytogenes infection in England & Wales (http://www.hpa.org.uk/Topics/In fectiousDiseases/InfectionsAZ/Listeria/Epidemiological Data/ listeQuestionnairesforthesurveillanceofListeria/). Accessed 1 June 2011.
14. British National Formulary. (http://bnf.org/bnf/). Accessed 3 June 2010.
15. NHS Prescription Services. (http://www.nhsbsa.nhs.uk/815.aspx). Accessed 9 July 2010.
16. Jensen A, Frederiksen W, Gerner-Smidt P. Risk factors for listeriosis in Denmark, 1989-1990. Scandinavian Journal of Infectious Diseases 1994; 26: 171-178. (Pubitemid 24141102)
17. Dalton CB, et al. A national case-control study of risk factors for listeriosis in Australia. Epidemiology and Infection 2010; 1-9.
18. Cobb CA, et al. Increased prevalence of Listeria monocytogenes in the faeces of patients receiving long-term H2-antagonists. European Journal of Gastroenterology and Hepatology 1996; 8: 1071-1074. (Pubitemid 26383864)
19. Ho JL, et al. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Archives of Internal Medicine 1986; 146: 520-524. (Pubitemid 16067899)
20. Gillespie IA, et al. Disease presentation in relation to infection foci for non-pregnancy-associated human listeriosis in England and Wales, 2001 to 2007. Journal of Clinical Microbiology 2009; 47: 3301-3307.
21. Chuang MH, et al. Listeria meningitis after infliximab treatment of ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition 2010; 50: 337-339.
22. Slifman NR, et al. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis and Rheumatism 2003; 48: 319-324. (Pubitemid 36277998)
23. Bowie VL, et al. Listeria meningitis associated with infliximab. Annals of Pharmacotherapy 2004; 38: 58-61. (Pubitemid 38018007)
24. Kesteman T, et al. Listeria infections associated with infliximab: Case reports. Clinical Rheumatology 2007; 26: 2173-2175. (Pubitemid 350120364)
25. Gluck T, et al. Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: Report of two cases. Arthritis and Rheumatism 2002; 46: 2255-2257.
26. WHO/FAO. Risk assessment of Listeria monocytogenes in ready-to-eat foods: Technical report (ftp://ftp.fao.org/docrep/fao/010/y5394e/y5394e.pdf). Accessed 1 June 2011.